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ABSTRACT
Objectives: The goal of weight reduction surgery is not
only to decrease excess weight, but also to improve obe-
sity related comorbidities and quality of life (QoL). Until
now, few studies have utilized objective methods to eval-
uate all of these issues. Hereafter, using the newly devel-
oped Moorehead-Ardelt Quality of Life Questionnaire II
(M-A QoLQ II) incorporated into the Bariatric Analysis and
Reporting Outcome System (BAROS), we report our re-
sults for patients undergoing laparoscopic adjustable gas-
tric banding (LAGB).
Methods: M-A QoLQ II questionnaires were sent to pa-
tients undergoing LAGB at a single institution. Nonre-
sponders were contacted by a second mailing and tele-
phone calls. The respondents’ data were scored according
to BAROS guidelines.
Results: Data from 67 patients with a mean follow-up of
27 months (22–35) were analyzed. Mean age was 43.8
years (range, 21 to 68) with a mean preoperative body
mass index (BMI) of 49.8 kg/m
2 (range, 38.4 to 67.7).
Mean postoperative BMI was 37.1 kg/m
2 (range, 23.0 to
53.4) for a mean excess weight loss (EWL) of 53.2%
(range, 7.5% to 108.6%). According to the BAROS scor-
ing system, 8 patients (12%) were classified as failures, 13
patients (19%) had fair, 24 (36%) had good, 13 (19%) had
very good, and 9 (13%) had excellent results. There was
considerable improvement in patient’s comorbidities, and
positive scores for self-esteem, and activity level.
Conclusions: The use of the M-A QoLQ II is an efficient
method of assessing the success of bariatric surgery.
Widespread use of the questionnaire would assist in stan-
dardizing reporting of results following bariatric surgery.
Our results suggest that LAGB may lead to excellent re-
sults with regards to resolution of comorbidities, improve-
ment in QoL, and overall weight loss.
Key Words: Laparoscopic adjustable gastric banding,
Quality of life, Bariatric Analysis and Reporting Outcome
System, Moorehead-Ardelt Quality of Life Questionnaire
II.
INTRODUCTION
Obesity is a chronic disease that has reached epidemic
proportions globally, with at least 300 million obese adults
worldwide.1 Obesity is associated with and contributes to
numerous physical and psychosocial disorders. Surgical
intervention is believed to be the most durable method of
weight loss among morbidly obese patients. Laparoscopic
adjustable gastric banding (LAGB) is one of the more
recent bariatric procedures that has emerged as a success-
ful means for surgical management of obesity. Currently,
no standardized methods exist for evaluating the efficacy
of LAGB or other bariatric procedures. In early studies, the
success or failure of LAGB was determined entirely based
on the amount of postoperative weight loss. This method
of evaluating the efficacy of the procedure using a single
variable raises 2 problems. First, there is no clear defini-
tion of successful weight loss as evidenced by the large
variability among studies as to what extent of total weight
loss constitutes success. Early criteria range from 15% of
initial weight loss to using a threshold of 50% loss of
excess weight to define a successful operation.2 Second,
this approach does not take into consideration the overall
impact of LAGB on the psychological and physical well
being of patients regardless of the absolute weight loss.
Some of these issues were addressed in the 1991 National
Institutes of Health (NIH) Consensus Development Con-
ference Draft Statement, which determined that “better
statistical reporting of surgical results is urgently needed
for better assessment of outcomes.” In addition, the NIH
declared “quality of life considerations in patients under-
going surgical treatment of obesity must be addressed.”3 It
is clear then that the most accurate assessment of the
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SCIENTIFIC PAPERsuccess or failure of a bariatric procedure should include
weight loss, improvements in medical conditions related
to morbid obesity, and improvements in quality of life.
The Bariatric Analysis and Reporting Outcome System
(BAROS), introduced by Oria and Moorehead in 1997,
fulfills the above requirements proposed by the NIH and
provides a standard for comparing outcomes of different
bariatric procedures, using a simple, objective, unbiased
method in an evidence-based fashion.2
The BAROS consists of a scoring system that includes 3
main areas of analysis: Weight Loss, Improvement of Med-
ical Conditions, and Quality of Life. Points are added or
subtracted according to changes in these domains. Points
are deducted for complications or reoperations. The total
number of points defines the 5 outcome groups (failure,
fair, good, very good, and excellent). Weight loss is ana-
lyzed by percentage of total excess weight loss (EWL).2
Changes in medical conditions related to obesity are an-
alyzed based on resolution or improvement of major and
minor comorbidities. The major comorbid conditions
taken into consideration by BAROS are hypertension, car-
diovascular disease, dyslipidemia, type II diabetes, sleep
apnea syndrome, and osteoarthritis. The minor comorbid
conditions include lower extremity venous stasis disease,
gastroesophageal reflux, and urinary stress incontinence.
Medical disorders are considered “resolved” when con-
trolled without medication and “improved” when con-
trolled by reduced doses of medication. Changes in qual-
ity of life following LAGB are analyzed by utilizing the
Moorehead-Ardelt Quality of Life Questionnaire II (M-A
QoLQII).4 Six items are used in the questionnaire for
measuring a patient’s subjective impression of QoL in the
areas of1: general self-esteem,2 physical activity,3 social
contacts,4 satisfaction concerning work,5 pleasure related
to sexuality, and6 focus on eating behavior. Points are
added or subtracted based on the patient’s responses. The
results of this questionnaire are then incorporated into the
BAROS to determine the final score.
The M-A QoLQII has been improved since its initial in-
ception in several ways. A question about food perception
has been added. Questions and graphic symbols were
revised to minimize the influence of “socially desirable” or
“culture-sensitive” responses. Additionally, all of the ques-
tions are equally weighted and a 10-point Likert scale is
used for scoring. The M-A QoLQII correlates well with
other widely used health and well-being indicators, and
the validity and reliability of its ability to assess QoL
measurement has been established.5–8
The original M-A QoLQ incorporated into the BAROS has
been used in several international studies to evaluate the
outcomes of LAGB, but to date few United States studies
have been published using the newly revised system.9–18
This report is one of the first in this country to use the M-A
QoLQII incorporated into the BAROS to evaluate a cohort
of patients who have undergone LAGB.
METHODS
A retrospective review of the first 120 patients who un-
derwent LAGB at our institution was performed. The cases
were performed by a single surgeon (VS) between No-
vember 2001 and November 2002. All patients, including
those who have since had their band removed, are in-
cluded in this study. After obtaining approval from the
Institutional Review Board and after appropriate permis-
sion to reproduce the M-A QoLQII was obtained, the
questionnaire, along with a survey of current weight and
comorbidity information, was mailed to each patient with
a cover letter explaining the voluntary nature of the study
(Figures 1 and 2). Nonrespondents were contacted by
phone, and a second mailing was sent approximately 6
weeks later. All responses were tabulated in a database,
and BAROS scores were assigned to each patient accord-
ing to the scoring systems established by Oria and Moore-
head2,8 (Figures 3 and 4).
RESULTS
Sixty-seven responses were received of the 120 question-
naires (56%) mailed out. Seventy-nine percent of respon-
dents were female. Fifty-three responses were received
after the first mailing, and the remaining 14 responses
were received after the second mailing and a follow-up
phone call. Mean age was 43.6 years (range, 21 to 68).
Preoperatively, the patients had a mean weight and BMI
of 142.5 kg (range, 92.3 to 214.1) and 49.8 kg/m
2 (range,
38.4 to 67.7), respectively. They had an average of 3.1
comorbidities (range, 0 to 8). After a mean follow-up of
27.4 months (range, 21.5 to 34.9), the patients achieved a
mean weight and BMI of 105.9 kg (range, 61.8 to 168.2)
and 37.1 kg/m
2 (range, 23.0 to 53.4), respectively. The
average EWL for the group was 53.2% (range, -7.5 to
108.6). Thirteen patients (19.4%) required repeat opera-
tive interventions. Five of these were for band removal, 4
for revision for band slippage, and 4 for port revisions/
replacements.
One patient (1.5%) experienced weight gain, 5 patients
(7.5%) reported between 0% EWL and 24.9% EWL, 28
(41.8%) reported 25% EWL to 49.9% EWL, 17 (25.4%)
reported 50% EWL to 74.9% EWL, and 16 patients (23.9%)
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patients reported that their medical conditions were ag-
gravated since LAGB, 21 (31.3%) reported no change in
their comorbidities, 19 (28.4%) reported that their comor-
bidities had improved, 17 (25.4%) reported that 1 major
comorbidity had resolved and others had improved, and 7
patients (10.4%) reported that all major comorbidities had
resolved and other minor ones had improved. Patients
also reported positive self-esteem and activity level scores
across all categories. The mean scores for how patients
feel about themselves was 0.3 (range, 0.5 to 0.5), enjoy-
ment of physical activity was 0.2 (range, 0.5 to 0.5),
satisfaction with social contacts was 0.3 (range, 0.3 to
0.5), ability to work was 0.3 (range, 0.5 to 0.5), pleasure
from sex was 0.3 (range, 0.5 to 0.5), and their approach
to food was 0.1 (range, 0.5 to 0.5).
To incorporate these results into the BAROS scoring sys-
tem, patients were divided into those with and those
without comorbidities. Of the 55 patients (82%) with co-
Figure 1. Moorehead-Ardelt Quality of Life Questionnaire II.
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patients (22%) had fair, 20 (36%) had good, 9 (16%) had
very good, and 7 (13%) had excellent results.
Twelve patients with no comorbidities (18%) were scored
using the modified scoring system2 (Table 1). According
to this system, 1 patient (8%) was classified as a failure, 1
(8%) had a fair outcome, 4 (33%) had good, 3 (25%) had
very good, and 3 (25%) had an excellent outcome. Com-
bining the scoring systems gave a final result of a 12%
failure rate, 19% fair, 36% good, 18% very good, and 15%
excellent results among all patients.
DISCUSSION
It is generally recognized that weight loss alone is not an
adequate measure of the success of a bariatric proce-
dure.2,14–19 Utilizing the BAROS scoring system, following
bariatric procedures, provides a means of assessing a
more global response to the intervention by considering
not only the %EWL, but also changes in medical condi-
tions and quality of life. The BAROS scoring system incor-
porating the Moorehead-Ardelt Quality of Life question-
naire has been used in several other studies; however, no
reports exist of utilizing the newest version (M-A QoLQ II)
of the quality of life questionnaire. The aforementioned
improvements in the questionnaire allow for pre- and
postsurgical assessment as well as comparison between
control groups. The new scoring scale makes the instru-
ment more sensitive and improves response-differentia-
tion.8 In the past, a host of different systems have been
used for assessing quality of life after bariatric surgery.
These include the Short Form 36 Health Survey (SF-36),
Impact of Weight on Quality of Life-Lite Questionnaire
(IWQOL-Lite), Gastrointestinal Quality of Life Index, and
the BAROS with the M-A QoLQ (original version), among
others.9,11,19–21 Several studies report an improvement in
the quality of life using all of the indices except the SF-36,
which has given inconsistent results.11,19,20 The incorpo-
ration of the M-A QoLQII into the BAROS has created a
simple, time efficient method of measuring outcomes fol-
lowing LAGB. The questionnaire can be completed in less
than 1 minute without the need for structured interviews,
assistance, or coaching. Our current analysis was con-
ducted retrospectively using mailings to patients who had
their initial procedure a minimum of 22 months before
receiving the mailings. This method of data collection
suffers from generally less than ideal response rates (56%
in our case). We plan to routinely incorporate the M-A
Figure 2. Weight and comorbidity questionnaire.
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ment visits, hoping to produce a follow-up report with
inclusion of a much higher percentage of patients and a
longer follow-up period. Coupling these data with preop-
erative BAROS scores will further enhance this study.
The BAROS scores established in our series compare fa-
vorably to several other gastric banding studies. Favretti15
with one of the largest series of 170 patients with greater
than 18-month follow-up reported a failure rate of 10%,
fair outcome in 42%, good (corresponding to our good
and very good category) outcome in 44%, and excellent
outcome in 4% of his patients. Promising results were also
published by Hell in a series of 30 patients with only a 3%
failure rate and 23% of patients achieving excellent re-
sults.16 Other reports, such as those by Victorzon, Wolf,
and Martikainen did not demonstrate any patients with
“excellent” BAROS scores and had failure rates of 12% to
50%.13,17,18
Some of the limitations to the BAROS scoring system
manifest when comparing different bariatric procedures.
For example, the BAROS scoring system does not account
for perioperative or subsequent weight-loss related mor-
tality (severe malnutrition or hepatic failure). As such,
Figure 3. Bariatric analysis and reporting outcome system (BAROS) with Moorehead-Ardelt Quality of Life Questionnaire II scoring key.
Table 1.
BAROS Modified Scoring Key for Patients Without
Comorbidities
Failure 0 points or less
Fair 0 to 1.5 points
Good 1.5 to 3 points
Very good 3 to 4.5 points
Excellent 4.5 to 6 points
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dence of mortality (such as biliopancreatic diversion) that
are also associated with the highest initial weight loss, as
a group, are likely to score the highest, using the BAROS
scoring system. A similar argument is likely to apply to
patients undergoing Roux-en-Y gastric bypass (RYGB). In
fact, excellent results after RYBG were noted in 63% of the
patients in the study by Hell, with a 0% failure rate.16
Nguyen21 reported excellent results in 25% and very good
results in 47% of the patients undergoing laparoscopic
RYBG 6 months after the operation. In regards to bilio-
pancreatic diversion (BPD), Marinari22 demonstrated
39.5% very good, and 23.2% excellent BAROS results in a
15-year follow-up study. Other reports demonstrate 63.3%
and 41.9% very good results after BPD.23,24 Recognizing
the impact of weight loss on the BAROS score and the
absence of any measure of mortality using the BAROS
scoring system, one has to be cautious comparing scores
reported for studies involving entirely different bariatric
procedures.
Length of follow-up is another factor not accounted for in
the BAROS scoring system. Just as survival following ther-
apy for cancer would be quite different depending on the
length of follow-up, the outcome of any bariatric proce-
dure should be strongly judged by the length of follow-
up. Weight loss after LAGB is gradual and steady, often
taking 2 years to 3 years to reach the 50%EWL to 60%EWL
range.25 Considering the major impact of weight loss
alone in the scoring system, any short-term report (2 years
or less) is likely to favor RYGB and BPD over LAGB with
regards to BAROS scores.
Our reoperation rate among the responders was 19.4%,
one third of which were due to port complications. This
reoperation rate is more than double our 8.6% reoperation
rate among our nearly 450 patients who have undergone
LAGB to date. Undoubtedly, with longer periods of fol-
low-up, the incidence of repeat operative procedures (in-
cluding port-related procedures, revision, and removal of
bands) can only increase. This phenomenon further
points out the significance of length of follow-up when
comparing different studies. Another explanation for this
difference in incidence of reoperation rates may be the
impact of our learning curve, as the patients in our current
report represent the first to undergo this procedure at our
institution.
CONCLUSION
Utilization of the new M-A QoLQII incorporated into the
BAROS provides a simple, standardized method of assess-
ing the outcome of LAGB patients. The questionnaire can
be given to patients preoperatively and on subsequent
follow-up visits to assess progress over time. The different
sections of the BAROS allow for differentiation between
success and failure from weight loss, change in comor-
bidities, or quality of life. More widespread use of this tool
will help provide better insight into the short- and long-
term effects of weight-loss surgery.
References
1. Waxman A. World health assembly. WHO global strategy on
diet, physical activity and health. Food & Nutrition Bulletin.
2004;25:292–302.
2. Oria HE, Moorehead MK. Bariatric analysis and reporting
outcome system (BAROS). Obes Surg. 1998;8:487–499.
3. National Institutes of Health Consensus Development Con-
ference Draft Statement. Gastrointestinal surgery for severe obe-
sity 25–27 March 1991. Obes Surg. 1991;1:257–266.
4. Oria HE. The BAROS and Moorehead-Ardelt Quality of Life
Questionnaire [correspondence]. Obes Surg. 2003;13:965.
5. Ware JE Jr., Sherbourne CD. The MOS 36-Item Short-Form
Health Survey (SF-36). Med Care. 1992;30:6.
6. Stunkard AJ, Messick S. Eating Inventory Manual. Toronto:
The Psychological Corporation; 1986.
7. Beck AT, Steer RA, Brown GK. Beck Depression Inventory –
II. Toronto: The Psychological Corporation; 1996.
8. Moorehead MK, Ardelt-Gattinger E, Lechner H, Oria HE. The
validation of the Moorehead-Ardelt Quality of Life Questionnaire
II. Obes Surg. 2003;13:684–692.
9. Dixon JB, O’Brien PE. Changes in co-morbidities and im-
provement in quality of life after Lap-Band placement. Am J
Surg. 2002;184:51S–54S.
10. Nini E, Slim K, Scesa JL, Chipponi J. Evaluation of laparo-
scopic bariatric surgery using the BAROS score [in French]. Ann
Chir. 2002;127:107–114.
11. Weiner R, Blanco-Engert R, Weiner S, Matkowitz R, Schaefer
L, Pomhoff I. Outcome after laparoscopic adjustable gastric
banding-8 years experience. Obes Surg. 2003;13:427–434.
12. Zinzindohoue F, Chevallier JM, Douard R, et al. Laparo-
scopic gastric banding: a minimally invasive surgical treatment
for morbid obesity. Ann Surg. 2003;237:1–9.
13. Martikainen T, Pirinen E, Alhava E, et al. Long-term results,
late complications and quality of life in a series of adjustable
gastric banding. Obes Surg. 2004;14:648–654.
14. Tolonen P, Victorzon M. Qualify of life following laparo-
scopic adjustable gastric banding-the Swedish band and the
Moorehead-Ardelt Questionnaire. Obes Surg. 2003;13:424–426.
JSLS (2006)10:414–420 41915. Favretti F, Cadiere GB, Segato G, et al. Bariatric Analysis and
Reporting Outcome System (BAROS) applied to laparoscopic
gastric banding patients. Obes Surg. 1998;8:500–504.
16. Hell E, Miller KA, Moorehead MK, Samuels N. Evaluation of
health status and quality of life after bariatric surgery: Compar-
ison of standard Roux-en-Y gastric bypass, vertical banded gas-
troplasty and laparoscopic adjustable silicone gastric banding.
Obes Surg. 2000;10:214–219.
17. Wolf AM, Falcone AR, Kortner B, Kuhlmann HW. BAROS: an
effective system to evaluate the results of patients after bariatric
surgery. Obes Surg. 2000;10:445–450.
18. Victorzon M, Tolonen P. Bariatric Analysis and Reporting
Outcome System (BAROS) following laparoscopic adjustable
gastric banding in Finland. Obes Surg. 2001;11:740–743.
19. Ballantyne GH. Measuring outcomes following bariatric surgery:
weight loss parameters, improvement in co-morbid conditions, change
in quality of life and patient satisfaction. Obes Surg. 2003;13:954–964.
20. Dymek MP, le Grange D, Neven K, Alverdy J. Quality of life
after gastric bypass surgery: a cross-sectional study. Obes Res.
2002;10:1135–1142.
21. Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic
versus open gastric bypass: a randomized study of outcomes,
quality of life, and costs. Ann Surg. 2001;234:279–291.
22. Marinari GM, Murelli F, Camerini G, et al. A 15-year evalu-
ation of biliopancreatic diversion according to the bariatric anal-
ysis reporting outcome system (BAROS).
23. Moneghini D, Mittempergher F, Terraroli C, DiFabio F. Bari-
atric Analysis and Reporting Outcome System (BAROS) follow-
ing biliopancreatic diversion. Annali italiani di chirurgia 2004;
75:417–420.
24. Elia M, Arribas D, Gracia JA, et al. Results of biliopancreatic
diversion after five years. Obes Surg. 2004;14:766–772.
25. O’Brien PE, Dixon JB. Lap-Band®: Outcomes and results. J
Laparoendosc Adv Surg Tech. 2003;13:265–270.
Quality of Life After Laparoscopic Adjustable Gastric Banding Using the Baros and Moorehead-Ardelt Quality of Life Questionnaire II,
Myers JA et al.
JSLS (2006)10:414–420 420